Experimental browser for the Atmosphere
Thousands of women with early breast cancer could be offered a drug to stop the cancer returning, after the medicines watchdog approved its use in England.
Apr 24, 2025, 5:27 PM
{ "uri": "at://did:plc:xj2vgfntckid2dl6sa6affmm/app.bsky.feed.post/3lnla5kgjac2a", "cid": "bafyreicjdulfodkwb47zptuief6y4ntc4kxr35ky5yph25hgumgt5jpux4", "value": { "text": "Thousands of women with early breast cancer could be offered a drug to stop the cancer returning, after the medicines watchdog approved its use in England.", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://www.theguardian.com/society/2025/apr/24/ribociclib-drug-cuts-risk-breast-cancer-returning-approved-england?CMP=Share_iOSApp_Other", "thumb": { "$type": "blob", "ref": { "$link": "bafkreib2qu6ntsjdb5dqp7iylut4u2h2rqwj3mbuywqdpucdoqhl4v7rim" }, "mimeType": "image/jpeg", "size": 306143 }, "title": "Drug that cuts risk of breast cancer returning is approved for use in England", "description": "Up to 4,000 patients a year with early stage of disease could receive ribociclib, but charities want wider access to drug" } }, "langs": [ "en" ], "createdAt": "2025-04-24T17:27:09.130Z" } }